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ABSTRACT
With some bacterial RNA polymerases and in
eukaryotic RNA polymerase 11, DNA melting during
initiation requires the coupling of energy derived from
3,B hydrolysis of ATP. A detailed analysis of this
possible requirement for eukaryotic RNA polymerase
I reveals no such requirement. However, in some
cases, fl,y non-hydrolyzable derivatives (,B,y imido or
methylene) of nucleotide substrates have been found
to significantly inhibit transcription initiation because
of their inefficient use as the first nucleotide of the
transcript. In addition, the results presented here show
that protein kinase activity is not required as an integral
part of transcription initiation by RNA polymerase 1.
Prior phosphorylation of proteins participating in the
process is not ruled out.
INTRODUCTION
During transcription initiation in enteric bacteria, the transition
from the closed to open (melted) DNA configuration may or may
not require hydrolysis of the 3,'y phosphodiester bond of ATP
depending upon the a subunit associated with the core enzyme
[reviewed in (1)]. Holoenzyme with the most prevalent a subunit,
a70, spontaneously catalyzes strand separation. Holoenzyme
with o-4, however, requires the presence of an additional protein
(phospho-NTRC, nitrogen regulatory protein C or phospho-
NR) bound to a distant enhancer site, but contacting the
polymerase by forming a DNA loop (2). An analogous reaction
involved in the melting of late T4 promoters has recently been
shown to involve DNA tracking of the enhancing protein rather
than DNA looping (3). The melting process stimulated by
phospho-NTRC (4) requires the hydrolysis of the fl,-y bond of
ATP (5); substitution of a 3,'y nonhydrolyzable ATP analog
inhibits phospho-NTRC-stimulated melting.
In eukaryotic cells, the three nuclear RNA polymerases exhibit
a differential ability to catalyze the melting reaction. RNA
polymerase HI appears to function at promoters in a manner
analogous to E. coli holoenzyme with a70; strand separation of
the DNA occurs spontaneously after assembly of the polymerase
at a promoter, in the absence of added nucleotide (6). Eukaryotic
RNA polymerase II, on the other hand, has a requirement for
ATP hydrolysis to make the transition from the closed to open
complex (7). Concomitant with this transition, a kinase or a
general transcription factor (eg. TFIIH) catalyzes multiple
phosphorylation of the C-terminal domain of the largest
polymerase subunit, at the expense of ATP j,'y hydrolysis
(8-10). Whether this reaction is involved in DNA strand
separation or in aiding the release of polymerase from its
association with other proteins in the vicinity of the promoter,
or in other reactions, is not clear. It is known, however, that
even polymerases missing the entire C-terminal domain require
ATP (,3y hydrolysis for initiation (9). Therefore, ATP hydrolysis
may be required both for aiding in the melting process and for
other events occurring during initiation by RNA polymerase II.
This phosphorylation event is required at each round of
transcription initiation by this enzyme. Unphosphorylated
polymerase II (Ha) enters the transcription cycle by binding to
the promoter. IHa then must be phosphorylated during initiation
and the transition to elongation (9,10). Polymerase II must be
dephosphorylated before it can enter into another round of
transcription; the phosphorylated form (LLO) cannot interact with
the promoter (11).
The situation with eukaryotic RNA polymerase I is less clear.
Kownin et al. (12) were able to show that Acanthamoeba RNA
polymerase I binding to promoters is mediated by protein-protein
contact with transcription initiation factors [TIF(s)] bound
upstream of the promoter and is DNA sequence-independent.
Bateman and Paule (13) showed that this complex is a closed
promoter complex, requiring the addition of nucleoside
triphosphates before strand separation can occur. In these
experiments, however, a short RNA product was synthesized,
and therefore it was not clear whether j,,y hydrolysis is required
for melting and initiation. Gokal et al. (14) and Schnapp and
Grummt (15) investigated the requirement for ATP f3Oy hydrolysis
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for mouse RNA polymerase I initiation. In their experiments,
the formation of the first phosphodiester bond of the transcript,
between ATP and CTP, rendered the resulting ternary complex
insensitive to inhibition by high salt, heparin or sarcosyl. Only
transcripts which had formed this first bond during a
preincubation produced a runoff product in a subsequent
incubation with all four nucleoside triphosphates and one of the
inhibitors. Formation of resistant complex was insensitive to
substitution of a nonhydrolyzable ATP analog. However, since
all of the preincubation reactions, save one, also contained
hydrolyzable CTP, the studies did not completely address a
possible requirement for nucleotide hydrolysis. In one
experiment, the preincubation of a dinucleoside phosphate, ApC,
in the absence of any nucleoside triphosphate also rendered the
complex insensitive to heparin during the subsequent elongation
phase (14). Thus the acquisition of heparin resistance did not
require 3,'y hydrolysis. The acquisition of heparin resistance,
however, is poorly understood in eukaryotes. In E.coli, attainment
of heparin resistance requires sigma subunit (a70) and the same
elevated temperature necessary for DNA strand separation.
Resistance is reversible as temperature is cycled between 20°C
and 12°C. Thus, heparin resistance seems not to be related to
initiation per se, but rather to the presence of a small melted
'bubble' in the DNA (16,17). In mouse, ApC probably results
in a region of melted DNA, as suggested by the sequence
specificity of dinucleoside phosphates' effect on transcription
(18,19). The attainment of heparin resistance in these experiments
may only indirectly be related to the normal melting process and
may not be related to normal initiation. Therefore, the
experiments presented here were undertaken, and they definitively
show the lack of requirement for NTP fry hydrolysis. We used
the Acanthamoeba system and an assay in which initiation can
be assayed without the addition of any fry hydrolyzable nucleoside
triphosphate or RNA primer and which does not rely upon ill
defined inhibitor resistance.
In addition, it has been shown that one of the transcription
factors utilized by RNA polymerase I (20), and perhaps RNA
polymerase I itself (21) must be in a phosphorylated state to
function properly. Furthermore, experiments in vivo and in vitro
have suggested that RNA polymerase I makes a transition from
a tanscriptionally competent form to an incompetent form at each
round of transcription (22). Since Paule and coworkers (23 -25)
have shown previously that eukaryotic ribosomal RNA
transcription is regulated by the amount of the active form of
RNA polymerase I, it is important to know whether initiation
by RNA polymerase I requires ATP or GTP ,3,'y hydrolysis,
perhaps indicative of phosphorylation during each round of
initiation.
MATERIALS AND METHODS
Preparation of nuclear extracts
Acanthamoeba nuclear extracts were prepared as described by
Zwick et al (26) except that nuclei were lysed in a final
ammonium sulfate concentration of0.5 M, not 0.3 M. The extract
was centrifuged at 100,OOOxg for 80 min at 40C. The resulting
supernatants were pooled, solid ammonium sulfate was added
to a final concentration of 1.82 M, and, following a 60 min
equilibration, the precipitated proteins were collected by
centrifugation at 100,OOOxg for 35 min at 40C. Again the
supernatants were pooled and solid amnmonium sulfate was added
equilibration, the precipitated proteins were collected by
centrifugation as above. The 1.82 M and 3.56 M ammonium
sulfate pellets were separately suspended in 1-2 ml of Buffer
C (50 mM HEPES/KOH, pH 7.9; 50 mM KC1; 0.1 M EDTA;
1 mM DTT; 0.5 mM PMSF; 10% glycerol) and dialyzed against
2 liters of Buffer C for 14 hours with buffer changes at 4 and
10 hours. As previously described (26), no RNA polymerase I
was detected in the suspension derived from the 1.82 M pellet.
The RNA polymerase I-specific transcription factors TIF-IB and
aUBF, however were in the 1.82 M ammonium sulfate fraction.
In contrast, all of the RNA polymerase I activity (but no detectable
TIF-IB or aUBF activity) fractionated with the 3.56 M
ammonium sulfate pellet.
Fractionation of nuclear extracts
The highly purified TIF used in this study was provided by
William Kubaska and was prepared as described previously (27).
(TIF as described here can be further resolved on Mono Q into
two components, TIF-IB and aUBF (Q.Yang and M.Paule,
unpublished). For the experiments described in this study, pre-
Mono Q TIF was used.) RNA polymerase I was purified from
the 3.56 M ammonium sulfate fraction ofAcanthamoeba nuclear
extracts by a scheme similar to that described by Spindler et al.
(28) except that BioRex 70 was substituted for Phosphocellulose
P11 and heparin Agarose was substituted for heparin Sepharose.
Briefly, the ammonium sulfate fraction (above) containing RNA
polymerase I activity was sequentially fractionated over BioRex
70, DEAE Cellulose (DE-52) and heparin Agarose.
Sedimentation of the pooled polymerase-containing fractions over
a 17.5-35% glycerol gradient resulted in near homogeneous
RNA polymerase I.
Plasmid DNAs and in vitro transcription reactions
Most transcription reactions presented in this study utilized 50
ng of a linearized plasmid which contained the in vivo
Acanthamoeba rRNA promoter and transcription initiation site
[pEBH1O; (29)]. The experiment presented in Figure 4 utilized
50 ng of a linearized DNA template containing the Acanthawnoeba
rRNA promoter, but containing an A to G transition at the site
of transcription initiation [pt+ A/G;(30)]. As previously
reported, this transition mutation has no appreciable affect on
initiation of transcription by RNA polymerase I at the
Acanthamoeba rRNA promoter (30). All transcription reactions
were performed as previously described (25,3 1) except that the
composition of nucleoside triphosphates was altered as indicated
in individual figure legends. All nucleoside triphosphates, or their
respective analogs, were used at a concentration of 500 FtM and
were Pharmacia Ultrapure Solution rNTPs (Pharmacia LKB
Biotechnology).
RESULTS
Some but not all 0,,y-nonhydrolyzable nucleotide analog
inhibit transcription
To examine whether an ATP 3,'y hydrolysis-dependent reaction
is required for initiation of transcriftion by Acanthamoeba RNA
polymerase I, we performed in vitro transcription reactions in
which ATP was replaced by analogs which had nonhydrolyzable
f,'y phosphoanhydride bonds. Neither 5'-adenylylimidodiphos-
phate (AMP-PNP) nor 1,'y-methyleneadenosine-5'-triphosphate
(AMP-PCP) could be efficiently substituted for ATP in our
to a final concentration of 3.56 M. Following a 60 min reconstituted transcription system (Figure 1, lanes 3 and 4). In
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Figure 1. Inhibition of gene-specific RNA polymerase I transcription by ATP
analogs containing non-hydrolyzable ,B-y phosphoanhydride bonds. Lane 1, no
RNA polymerase I; lanes 2-6 contain 30 mUnits RNA polymerase I. 500 zM
of 5'-adenylylimidodiphosphate (AMP-PNP) (lane 3) or 0--y-methyleneadeno-
sine-5'-triphosphate (AMP-PCP) (ane 4) was substituted for ATP. 500 JsM of
either 5 '-guanylylimidodiphosphate (GMP-PNP) (lane 5) or O3-y-
methyleneguanosine-5'-triphosphate (GMP-PCP) (ane 6) was substituted for GTP.
Gene-specific in vitro transcription was perfonned as described (25,31).
+ AMP-PCP~~~~~~~~~~~~
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Figure 2. Inhibition by AMP-PCP can be reversed by either ATP or dATP, but
not by other ATP analogs containing hydrolyzable 03-y phosphoanhydride bonds
which can't be incorporated into RNA. Lanes 1-5; standard tan on reactions
(25) which contained 500 IAM ATP (lane 1), 2'deoxyATP (dATP) Oane 2),
2',3'dideoxyATP (ddATP) (lane 3), adenine-9-a-D-arabinofuranoside
5'-triphosphate (ara-ATP) (ane 4) or AMP-CPP Oane 5). Lanes 6-11; standard
transcription reactions which contained 500 ItM AMP-PCP in place ofATP and
were supplemented, following a 10 minute preincubation, with no additional
nucleoside triphosphate (lane 6), or with 500 ytM ATP (lane 7), dATP (lane 8),
ddATP (lane 9), ara-ATP (lane 10), or et, -methyleneadenosine-5'-triphosphate
(AMP-CPP) Oane 11). Lane 12; standard transcription reaction which contained
500 ltM adenosine-5'-0-(3-thiotriphosphate) [ATP--y-S] in place of ATP.
contrast, the analogous GTP analogs, GMP-PNP and GMP-PCP,
had no discernable effect on specific transcription from the
Acanthamoeba rRNA gene promoter (Figure 1, lanes 5 and 6).
Interestingly, both ATP and GTP analogs had similar effects on
the ability of RNA polymerase I to catalyze RNA synthesis
nonspecifically from naked calfthymus DNA. Each of the analogs
reduced the nonspecific transcriptional activity of RNA
polymerase I by approximately 60% (data not shown).
Presumably the analogs have differential effects on specific
transcription because elongation is not the rate limiting step in
runoff transcription from a promoter.
As with other studies that have examined the energy
requirements for initiation of transcription, the inhibition of RNA
polymerase I activity we observed when substituting either AMP-
PCP or AMP-PNP for ATP could be relieved when reactions
were supplemented with ATP or dATP (Figure 2, lanes 7 and
8). In contrast to other studies, however, dideoxyATP, araATP
or AMP-CPP, each of which contain a hydrolyzable (,"y
phosphoanhydride bond but which cannot be incorporated into
RNA, did not relieve the inhibitory effect of AMP-PCP
(Figure 2, lanes 9-11). Therefore, we questioned whether the
observed inhibitory effect ofAMP-PCP on transcription initiation
was due to a specific ATP-dependent energy or phosphorylation
requirement.
RNA primers relieve the inhibitory effect
Since the immediate 5'-sequence of the nascent Acanthamoeba
rRNA transcript is 5'-pppAAAGGGAC (19), we reasoned that
AMP-PCP inhibition ofRNA polymerase I transcription initiation
might occur if the analog were a poor substrate for the initial
nucleotide of the specific transcript. During this reaction, the 5'
nucleotide is occupying a site on the enzyme normally containing
the 3' OH terminus of the nascent RNA. There is extensive
evidence for the uniqueness of this site in the E. coli polymerase
[reviewed in (32)]. By analogy, a homologous site should be
present in eukaryotic polymerases. The similarity of the effect
of dinucleoside phosphate primers in the E. coli and eukaryotic
polymerases (18,19) is in accord with this notion of a product
terminus site. We have demonstrated, using nonspecific
polymerase assays, that AMP-PCP can be utilized for elongation
of RNA, albeit less efficiently than ATP (not shown). To test
the idea that the analog might not be used efficiently in the product
terminus site, we supplemented AMP-PCP inhibited transcription
reactions with either the dinucleotide primer ApA (Figure 3, lane
4) or the trinucleotide primer ApApA (data not shown). Both
RNA primers relieved the inhibitory effect. The ability of the
RNA primers to restore transcription to normal levels is not a
result of ATP contamination of the primer since the wrong
dinucleotide primer, GpA, could not relieve the inhibitory effect
of AMP-PCP (Figure 3, lane 5, and results below)and addition
of the primer in place of ATP or its analog did not lead to
transcription (not shown). Similarly, since no RNA synthesis was
observed in the presence of the analog and a combination of the
other three nucleotides, GTP, CTP and UTP (Figure 3, lane 2),
we conclude that the nucleotide preparations are free of ATP.
Inhibition is due to an inefficient use of the ATP analog as
the initiating nucleotide
To further investigate the idea that the ATP analogs AMP-PCP
and AMP-PNP inhibit synthesis of wild-type Acanthamoeba
rRNA by functioning as poor substrates for the initial nucleotide
and not by interfering with an energy coupling or phosphorylation
step, we performed in vitro transcription reactions on a mutant
Acanthanoeba rDNA template (30) in which the initial nucleotide
(adenosine) of the wild-type DNA was replaced by a guanosine
residue in the RNA-like strand. The immediate 5'-sequence of
the resulting nascent rRNA is 5'-pppGAAGGGAC. In marked
contrast to transcription from the wild-type template, AMP-PCP
had no inhibitory effect on initiation of transcription from this
mutant template (Figure 4, lane 2). Interestingly, the analogous
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Figure 3. AMP-PCP inhibition of rRNA gene transcription can be relieved by
either ATP or the dinucleotide ApA. Lane 1; standard transcription reaction
containing 500 ItM ATP, Lanes 2-5; standard transcription reactions which
contained 500 uM AMP-PCP in place of ATP and supplemented, following a
10 minute preincubation, with no additional nucleoside triphosphate (lane 2), 500





FIgure 4. Neither ATP nor GTP analogs contafining. non-hydrolyzable j3--y
phosphoanhydride bonds inhibit transcrnption from a mutant rRNA template
containing guanosine instead of adenosine as the finitial nucleotide (30). Lane 1;
control. Lanes 2-4; standard tr-ancription reactions of a +I A/G point mutant
template in which 500 ltM AMP-PCP (lane 2), GMP-PCP lane 3) or both were
substituted for ATP or GTP, respectively.
GTP analog, GMP-PCP, also had no effect on transcription from
the mutant template (Figure 4, lane 3). The lack of any detectable
inhibition by GMP-PCP was not a result of contaminating GTP
in the preparation since the level of GTP contamination, 0.2%,
was not enough to allow for the observed wild-type levels ofRNA
synthesis when using the analog alone [data not shown and (19)].
Another ATP analog, ATP-'yS, had no inhibitory effect on
transcription of the wild type template by RNA polymerase I
(Figure 2, lane 12) suggesting that inhibition is analog-dependent
(see Discussion).
We infer that the inhibition caused by AMP-PCP on the wild
type template is not due to contamination with some nonspecific
inhibitor. The analog does not inhibit nonspecific transcription















Figure 5. Complete substitution of 03,y-nonhydrolyzable nucleotide analogs has
no inhibitory effect on stable DNA strand separation during initiation by polymerase
I. Analysis of single-stranded DNA was carried out using diethylpyrocarbonate
modification of adenosines (13) on the wild-type (left panel) or + 1 A/G point
mutant (right panel) templates. No pyrimidine nucleoside triphosphates are present
in these assays. Purine nucleotides or analogs were added as shown. Positions
modified by DEPC were determiined by comparison to DNA sequencing ladders
[not shown and ref (13)]. Note that in the pt+I A/G mutant, the A at position
+ 1 normally modified by DEPC in the wild type template is a G and is not
modified. This internally confilms the assignment of the modified positions since
the + 1 band is missing in the mutant (right panel).
Specific inhibition is only overcome witi primers which match
the initiation site. AMP-PCP does not inhibit on a template
encoding RNA beginning with G instead of A, even when present
at a concentration equal to that which inhibits transcription from
a wild type template.
Finally, while both AMP-PCP and GMP-PCP analogs inhibit
elongation initiated artificially on naked DNA template containing
nicks and single-stranded regions by 60% (not shown), even a
combination of the two analogs has no apparent effect on specific
initiation at a committed complex on the +1 A/G promoter
measured by a runoff assay. This suggests that, as previously
shown for mouse RNA polymerase I, the rate limiting step in
a specific runoff assay is the transition from the closed initiation
complex to the elongation complex, rather than the elongation
rate (14,33,34).
Protein kinase activity appears unnecessary for initiation
Even a combination of both non-hydrolyzable purine nucleoside
triphosphate analogs (Figure 4, lane 4) had no inhibitory effect
on transcription of the mutant template further supporting the
notion that no phosphorylation event by a kinase specific for
purine nucleotides is required for initiation by RNA polymerase
I. To further eliminate the possibility that transcription involves
a reversible tyrosine phosphorylation step during initiation, either
staurosporin, a potent protein kinase C and tyrosine kinase
inhibitor (35), or genistein, a specific inhibitor of tyrosine protein
kinases (36), was included in in vitro transcription reactions.
Inclusion of these inhibitors at concentrations up to 10-5 M had
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Stable DNA strand separation requires addition of purine
nucleotide substrates, but does not require 3,'y-hydrolysis
We directly tested the effect of AMP-PCP plus GMP-PCP on
melting of the wild type and + 1 A/G point mutant. Bateman
and Paule (13) had observed previously that melting can be
detected by single-strand-specific modification of adenosine
residues by diethylpyrocarbonate (DEPC). In those experiments,
it was determined that the formation of a stable melted region
of the template does not occur until after an RNA product of
several nucleotides is synthesized. We presume, however, that
rapid isomerization between closed and open states must occur
to allow the first nucleotides to be aligned with the template
strand. In agreement with this, we find susceptibility to DEPC
(at positions -2, +2, 3, 7) of the + 1 A/G mutant template is
only observed after nucleotides have been added (Figure 5, right
panel, compare lanes 1 and 2 with 3). As above, hydrolysis of
the 3,'y-phosphoanhydride bond is not required for melting
because AMP-PCP plus GMP-PCP can be substituted for normal
nucleotides in this reaction on the +1 A/G point mutant
(Figure 5, lane 4). Note that in this assay, unlike in the
transcription assays, no normal pyrimidine nucleotides are
present. Thus energy coupling or phosphorylation cannot be
mediated by enzymes using pyrimidine nucleoside triphosphates.
This contrasts with experiments done previously in the mouse
system (14,15) (see Introduction). Just as is observed for
transcription, melting (at positions -2, + 1, 2, 3, 7) is not as
efficient on the wild type template when the analogs are
substituted. A low degree of melting is detectable, however
(Figure 5, left panel), in accord with the weak transcription of
this template when AMP-PCP is used (Figure 1).
DISCUSSION
Results presented here demonstrate that 3,,y hydrolysis of
nucleotides is not required for strand separation during initiation
by RNA polymerase I, in contrast to eukaryotic polymerase II.
Formation of a stable melted DNA region occurs as a separate
step following binding ofRNA polymerases to DNA. For RNA
polymerases I and II, melting also requires the addition of
nucleotide precursors (7,13). The melting and initiation step of
polymerase II is inhibited by AMP-PCP. However, neither AMP-
PCP nor GMP-PCP, nor a combination of both of them, inhibits
polymerase I because of a requirement for (3,y bond hydrolysis,
even under conditions in which the two analogs are the only
nucleotides in the reaction.
Our results suggest caution in interpreting inhibition by these
analogs when studying transcription, however. These analogs
may not serve effectively as the initiating (first) nucleotide of
the transcript, a reaction in which the initiating nucleoside
triphosphate binds to the 3'-OH product terminus site on the
polymerase (32). This binding is inefficient as demonstrated by
the requirement for a high concentration of the initial nucleotide
(19,37). This product terminus site has different structural
requirements that the 'elongation nucleotide site' in E. coli. For
example, magnesium is not required, nor is a triphosphate group
[reviewed in (32)]. Dinucleotide RNA primers have previously
been shown effective in priming rRNA synthesis when the
concentration of initiating nucleotide is insufficient (19,38), and
we show in the present study that AMP-PCP-mediated inhibition
of Acanthamoeba rRNA transcription also can be completely
relieved by supplementing an AMP-PCP-inhibited reaction with
the dinucleotide RNA primer, ApA (Figure 3, lane 4). Inhibition
could also be relieved by ATP, dATP (to a lesser degree, see
below), but not by other 3,y-hydrolyzable ATP analogs which
can't be incorporated into RNA. Significantly, inhibition was
completely eliminated by changing the initial nucleotide encoded
in the template from A to G (Figure 4) indicating a template
sequence dependence rather than a nucleotide dependence for
ATP. Since the mutant template is not inhibited by GMP-PCP,
perhaps inhibition by AMP-PCP on the wild type template arises
because of an inability of the polymerase to properly align two
ATP analogs to form the first phosphodiester bond. In contrast,
alignment is not significantly anomalous when elongating a
nascent RNA, dinucleoside phosphate primer or when GMP-PCP
is the first nucleotide and AMP-PCP is the second. The inhibitory
effect also appears to be dependent upon the specific analogs being
aligned since ATP--yS can replace ATP on the wild type template
(Figure 2, lane 12). The ability of dATP to partially relieve the
inhibitory effects ofAMP-PCP on wild type template is in accord
with the finding that dATP can be incorporated as the initial
nucleotide by RNA polymerase II and may also function as a
poor substrate for elongation [Figure 2, lanes 2, 8 and see (39)].
Polymerase I may also follow this model. Alternatively, there
may be some low level ATP contamination in our dATP
preparation.
The results presented here and elsewhere (14,15) have profound
implications not only for the mechanism of initiation by RNA
polymerase I, but in addition, for the mechanism of regulation
of rRNA expression. Preinitiation complexes form at the
Acanthamoeba rRNA gene promoter in the absence of nucleotides
(25). Results presented here indicate that neither exposure to
tyrosine protein kinase inhibitors nor blocking of purine
nucleoside triphosphate 3,By bond hydrolysis had detectable effects
on transcription in vitro. Casein kinase U-related kinases
characteristically require ATP or GTP as substrates. The
alternative possibility that a required kinase is specific for
pynimidine nucleoside triphosphates can be ruled out because
initiation occurs efficiently with both purine analogs in the absence
of CTP and UTP, producing a 7 nucleotide long product,
pppAAAGGGA or pppGAAGGGA (Figure 5). These
observations lead us to conclude that transcription by
Acanthamoeba RNA polymerase I requires neither factor nor
polymerase phosphorylation as an integral part of each round of
initiation. This is not to say that a phosphorylation mechanism
may not be involved in regulation of rRNA transcription
(20,21,24,25), but only that phosphorylation is not required at
each round of initiation as for eukaryotic RNA polymerase II
(see Introduction).
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